Chengjie Ke

8PUBLICATIONS
10CO-AUTHORS
Epidemiological modellingToxicology (incl. clinical toxicology)Pharmaceutical delivery technologiesPharmacology and pharmaceutical sciences not elsewhere classifiedPharmacogenomics
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (8)

|May 09, 2026
A real-world pharmacovigilance study of dacomitinib based on FDA adverse event reporting system (FAERS) database.

|Oct 16, 2025
Safety assessment of voclosporin: a real-world disproportionality analysis of the FAERS database.

Min Chen, Yaping Huang, Chengjie Ke

|Jul 27, 2025
Safety Assessment of Ritlecitinib Based on the FDA Adverse Event Reporting System (FAERS) Database: A Real-World Pharmacovigilance Study.

Yaping Huang, Chengjie Ke, Maohua Chen

|Jun 12, 2025
Pharmacovigilance Analysis of Lifitegrast-Associated Adverse Events Using the FDA Adverse Event Reporting System (FAERS) Database.

Dongzhi Wu, Zhijing Liu, Tao Zhang

|Feb 17, 2025
Physiologically based pharmacokinetic model for oxcarbazepine active metabolite to predict pharmacokinetics in paediatric patients with renal impairment and adjust dosages.

Cheng-Jie Ke, Si-Ting Liu, Yu-Die Qian

|Dec 05, 2024
Safety assessment of tafamidis: a real-world adverse event analysis from the FAERS database.

Min Chen, Yaping Huang, Chengjie Ke

Pageof 2

Frequent Collaborators

7 joint publications

Maohua Chen

3 joint publications

Yaping Huang

1 joint publications

Si-Ting Liu

1 joint publications

Yu-Die Qian